Lipoprotein lipase deficiency arising in type V dyslipidemia

  • Sho Tanaka
  • , Takahiro Ueno
  • , Akiko Tsunemi
  • , Yoshihiro Nakamura
  • , Hiroki Kobayashi
  • , Yoshinari Hatanaka
  • , Akira Haketa
  • , Noboru Fukuda
  • , Masayoshi Soma
  • , Masanori Abe

    Research output: Contribution to journalArticlepeer-review

    4 Citations (Scopus)

    Abstract

    A 40-year-old Japanese man presented with child-onset hypertriglyceridemia recently complicated by diabetes mellitus. The patient’s diabetes mellitus was maintained, but he had persistent insulin resistance. The patient also had persistent severe hypertriglyceridemia (1,224-4,104 mg/dL), despite the administration of bezafibrate and ezetimibe. Type V dyslipidemia was revealed by agarose gel electrophoresis and the refrigerator test, and a significantly reduced post-heparin lipoprotein lipase mass of 26 ng/mL was confirmed. Genetic testing confirmed two heterozygous LPL variants, p.Tyr88X and p.Gly215Glu in trans; thus, the patient was diagnosed with lipoprotein lipase deficiency. Lipoprotein lipase deficiency typically arises in type I dyslipidemia, but is latent in type V dyslipidemia.

    Original languageEnglish
    Pages (from-to)251-257
    Number of pages7
    JournalInternal Medicine
    Volume58
    Issue number2
    DOIs
    Publication statusPublished - 15 Jan 2019

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • Chylomicronemia
    • Lipoprotein lipase
    • Triglycerides

    Fingerprint

    Dive into the research topics of 'Lipoprotein lipase deficiency arising in type V dyslipidemia'. Together they form a unique fingerprint.

    Cite this